Detalles de la búsqueda
1.
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials.
Gastric Cancer
; 25(3): 640-651, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35129727
2.
A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report.
BMC Cancer
; 18(1): 92, 2018 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29357824
3.
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation.
Prostate
; 76(1): 32-40, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26390914
4.
A phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.
BMC Cancer
; 16: 644, 2016 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27535748
5.
Treatment decision-making during outpatient clinic visit of patients with esophagogastric cancer. The perspectives of clinicians and patients, a mixed method, multiple case study.
Cancer Med
; 11(12): 2427-2444, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35166037
6.
Effects of an Integrated Palliative Care Pathway: More Proactive GPs, Well Timed, and Less Acute Care: A Clustered, Partially Controlled Before-After Study.
J Am Med Dir Assoc
; 22(2): 297-304, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33221300
7.
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer.
Nat Commun
; 11(1): 525, 2020 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31988276
Resultados
1 -
7
de 7
1
Próxima >
>>